Growth Opportunities in Precision Medical Imaging, Forecast to 2022
A Market Opportunity Assessment of Medical Imaging‘s Flourishing Contribution to Personalized Medicine Initiatives
  • The precision medicine paradigm has found its early roots in genetic profiling, as genomics have proven their potential in helping clinicians decide on the right treatment for the right patient at the right time. Not far behind is medical imaging, which is rapidly developing its own, image-based approaches to tailoring decisions and care pathways to individual patients. Indeed, as one of only four ways to phenotype a patient, – together with clinical history through physical examination, lab testing, and pathology – diagnostic imaging provides a fundamental source of information for personalized medicine.

    At every step of the medical imaging value chain, opportunities are developing for a personalized approach to imaging, away from a one-size fits-all model: from ordering and planning imaging studies, to imaging equipment advances and personalized image acquisitions, to precision reporting and image analysis with quantitative imaging biomarkers and radiomics, to image-based 3D printing and real-time image-guided interventions and therapies, to high-precision radiation therapy and molecular imaging of theranostic radiotracers, and with the overarching analytics layer that closed the loop on imaging's value, quality and outcomes. Precision imaging’s impact is expected across the key clinical application areas of oncology, metabolic diseases and neurological disorders, and the paradigm itself is expected to result from the convergence of several developments, including but not limited to integrated and structured big imaging datasets, multi-modal techniques in multidisciplinary care, and personalization under a consumerist paradigm.

    Every major economy has launched wide-scale precision medicine projects over the last few years, involving genetic profiling of millions of people. Medical imaging is now the next in line, as the interest in imaging biobanks and registries and the confidence in image-based cohort creation and therapy selection and planning are growing rapidly. While all of the major imaging companies have taken notice of the "precision imaging" opportunity, their respective approaches and proactive levels vary widely.

    • Get Access to Complimentary Intelligence
    • * indicates mandatory fields
    • Firstname*
    • Lastname*
    • Company*
    • Job Title*
    • Business Phone*
    • Business Email*
    • Job Role*
    • Country*
    • Are you in the media?*
    • We'd love to send you exclusive offers and the latest info from Frost & Sullivan in the areas of:
    • Research & Analysis - Free Trial Access
      • Businesses across the globe are fast evolving and time is of the essence. Today’s leaders do not lack for a wealth of data, but rather the ability to find answers quickly. Frost & Sullivan’s research delivery platform provides actionable intelligence through an intuitive platform to ensure customers gain answers to critical questions faster than ever before.
    • Scheduling a Growth Workshop or customized Consulting project
      • Frost & Sullivan’s Growth Consulting Model provides specific tools and expertise to support clients through all five phases of the growth cycle: From developing a pipeline of growth opportunities to evaluating and prioritizing those opportunities to formulating and implementing go-to-market strategies to ongoing monitoring. The objective of the Growth Model is to identify your company’s Growth Zone and help you capture the most attractive opportunities.
    • Complimentary Growth Strategy Dialogue
      • Talk to an analyst today to know more by signing up for a complimentary Growth Strategy Dialogue, an interactive conversation with an analyst regarding growth opportunities in your market.
    • Please tick the boxes below to tell us all the ways you would prefer to hear from us:
    • Frost & Sullivan values your privacy and we will never share or sell your personal information to third parties. Please visit our Privacy Policy.